A Highly Lipophilic Sirolimus Analogue
Designed to Inhibit Smooth Muscle Cell Proliferation
Complete Drug Elution
I. Endeavor System Key Benefits
II. Endeavor Design
III. Endeavor Stent Clinical Trials
V. Resources
Contact
The ABT-578 drug on the stent is delivered in a timely fashion into the vessel wall.
